KAPA – kairos pharma, ltd. (US:NASDAQ)
Stock Stats
News
Kairos Pharma Provides Shareholder Update
Kairos Pharma Presents on Phase 2 Trial of ENV-105 in Advanced Prostate Cancer at European Society Medical Oncologists (ESMO) Meeting
Kairos Pharma to Present Positive Safety and Efficacy Data from Phase 2 Prostate Cancer Trial at ESMO 2025 [Yahoo! Finance]
Kairos Pharma to Present Positive Safety and Efficacy Data from Phase 2 Prostate Cancer Trial at ESMO 2025
Kairos Pharma Announces Positive Interim Efficacy Analysis of Phase 2 Trial of ENV105 in Advanced Prostate Cancer with Median Progression Free Survival of Over One Year
Form 4 Kairos Pharma, LTD. For: Oct 08 Filed by: Murali Ramachandran
Form 4 Kairos Pharma, LTD. For: Sep 16 Filed by: Keyoung Hansoo Michael
Form 4 Kairos Pharma, LTD. For: Oct 08 Filed by: Singhvi Rahul
Form 4 Kairos Pharma, LTD. For: Oct 08 Filed by: Samuelson Doug
Form 4 Kairos Pharma, LTD. For: Oct 08 Filed by: Yu John S
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.